Increased Sun Sensitivity May Be Caused by Prescription

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
220
Increased Sun Sensitivity May Be Caused by Prescription Drugs

Photosensitivity is a condition where an individual’s skin burns easily and becomes sensitive to sunlight or artificial UV light. It often causes sunburns or rashes, particularly where skin is exposed to the light. Phototoxicity is a common reaction to photosensitivity, causing a sunburn-like effect on an individual’s skin shortly after sunlight exposure. A less common reaction, photoallergy, appears days after a person has been out in the sun.

Experts believe that some medications may cause increased sensitivity to the sun, noting that managing this with sunscreen alone may not be enough. Dr. Anthony Fernandez, a dermatologist, explains that combining certain drugs with both UVA and UVB light from the sun causes inflammatory and toxic reactions that are harmful for skin cells.

Both over-the-counter and prescription drugs can cause such reactions, including ibuprofen, antibiotics such as ciprofloxacin, diabetes drugs such as glimepride and glyburide, and birth control pills. The skin can also react to medications, including acne medications such as isotretinoin, diuretics such as furosemide, nonsteroidal anti-inflammatory drugs for arthritis, and tricyclic antidepressants such as nortriptyline, among many other medications.

It should be noted, however, that people react differently to drugs and anyone can get exaggerated sunburns because of medications, regardless of their skin color. To minimize these drug-induced reactions, Fernandez recommends avoiding excessive exposure to the sun and wearing protective clothing such as long sleeves and broad-brimmed hats. He notes that being exposed to sunlight while driving or through windows at home may also cause a reaction.

In addition to this, the American Academy of Dermatology Association recommends the use of sunscreen. Sunscreen is the most effective when applied 15 to 30 minutes before going out if the sunscreen protects against UVA and UVB light, if it is reapplied every two hours and if the entire body is covered. Therefore, you should check your sunscreen’s expiration date before use.

Additionally, individuals who are more sensitive to sunlight in general may benefit from avoiding the sun between 10 a.m. and 2 p.m. because s these are peak hours of intensity. People on medications are also advised to check with a pharmacist or healthcare provider if they’re not sure whether the drugs they take may pose a risk.

Alternatively, one can check out the FDA’s list of drugs that can cause sun sensitivity if they’re not sure whether photosensitivity is a side effect of a drug they’re on. It is important to protect your skin when you’re in the sun, regardless of whether or not you’re on medication.

If you develop burns as a result of sun exposure, it may be wise to quickly use readily available topical products available from many firms such as Jupiter Wellness Inc. (NASDAQ: JUPW) to minimize the resulting skin damage while you seek professional help.

NOTE TO INVESTORS: The latest news and updates relating to Jupiter Wellness Inc. (NASDAQ: JUPW) are available in the company’s newsroom at https://ibn.fm/JUPW

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer


Jupiter Wellness Inc. (JUPW) Stock Research Links

JUPW Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 608

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 23

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 149

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 124

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 38

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 467

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 187

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 101

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Homebuyers Benefit as Mortgage Rates Hit New Lows

Updated Category News Views 110

Mortgage Rates See a Significant Drop Recent data shows that mortgage rates have fallen to their lowest point in more than 18 months. This presents a prime opportunity for homebuyers who might be thinking about refinancing their current loans. The drop in rates can be linked to various market dynamics, which has led to a noticeable spike in refinancing activity. Current...

Continue Reading
Cross River Bank Launches Innovative FDIC Sweep Service

Updated Category News Views 195

Introducing Cross River's Automated Sweep Feature Cross River Bank, a pioneering technology infrastructure provider known for its innovative embedded financial solutions, has recently unveiled its automated sweep feature leveraging the IntraFi Cash Service. This groundbreaking service allows Cross River's Banking-as-a-Service (BaaS) clients to access enhanced FDIC...

Continue Reading
Understanding P/E Ratio and Its Importance for PNC Investors

Updated Category News Views 198

Understanding the P/E Ratio for PNC Financial Services Group In today’s trading session, PNC Financial Services Group’s stock is valued at $187.43, reflecting a slight increase of 0.87%. Looking at the broader picture, the stock of PNC Financial Services Group Inc. has risen by an impressive 4.19% over the past month and a remarkable 63.74% in the past year. These...

Continue Reading
Grace Therapeutics Sees Positive Outcomes and Business Growth

Updated Category News Views 224

Grace Therapeutics Reports Promising Progress and Financial Update Grace Therapeutics, Inc. (NASDAQ: GRCE), a biopharmaceutical company dedicated to advancing treatment solutions, has just shared significant news regarding its fiscal operations and pivotal clinical advancements. The company focuses on developing GTx-104, a promising injectable formulation of nimodipine...

Continue Reading
Jordan G. Welch's Worship Culture Tour: A Transformative Experience

Updated Category News Views 643

Jordan G. Welch's Worship Culture Tour Unleashes New Dimensions in Worship The Worship Culture Tour is set to launch with a vibrant focus on creating an immersive worship experience that extends beyond traditional confines. This exciting two-day event will guide participants through a journey of spiritual growth across multiple cities, inviting people from all walks of...

Continue Reading